Searcharxiv⌕ Search

arXiv subjects

Franca Wagner

Publications and source records attributed to Franca Wagner.

3 recordsLinked to original sources

SWIMSS: An Open Multi-Center SwinUNETR Model for Multiple Sclerosis White Matter Lesion Segmentation

Purpose: To develop and validate SWIMSS (SWInUNETR for Multiple Sclerosis white matter lesion Segmentation), a SwinUNETR-based deep learning (DL) model for reliable automated white matter (WM) lesion segmentation, in a large multicentric cohort of people with multiple sclerosis (pwMS). Methods: A real-world longitudinal dataset of 1,385 pwMS from seven Swiss clinical centers was used to train, validate, and test SWIMSS and two state-of-the-art DL architectures: UNETR and MSSegDiff. Inference results obtained with LST-AI were also compared. Preprocessed magnetization-prepared rapid acquisition gradient echo and fluid-attenuated inversion recovery MRI sequences, acquired with various MR systems and field strengths, served as model inputs. Model performance was evaluated using the Dice similarity coefficient (DSC) with 95% confidence intervals (CI). Results: SWIMSS achieved the highest performance, with a DSC of 81.37 (95% CI: 80.63-82.11), outperforming UNETR (79.06; 95% CI: 78.33-79.79), MSSegDiff (75.70; 95% CI: 74.97-76.43), and LST-AI (63.19; 95% CI: 62.08-64.30). Normalized DSC followed a similar trend, with SWIMSS reaching 84.88. Lesion detection F1 achieved 81.14. Statistical analyses confirmed its superior performance (p < 0.001). Conclusion: SWIMSS achieved state-of-the-art performance for WM lesion segmentation. By making this model publicly available, we enable broader access to high-quality segmentation tools, allowing smaller centers, often lacking large annotated datasets or computational resources, to benefit from a model trained on a diverse, large-scale cohort. This promotes more equitable access to advanced imaging analysis and supports reproducibility and standardization in MS research.

eess.IV↗

Simultaneous lesion and neuroanatomy segmentation in Multiple Sclerosis using deep neural networks

Segmentation of white matter lesions and deep grey matter structures is an important task in the quantification of magnetic resonance imaging in multiple sclerosis. In this paper we explore segmentation solutions based on convolutional neural networks (CNNs) for providing fast, reliable segmentations of lesions and grey-matter structures in multi-modal MR imaging, and the performance of these methods when applied to out-of-centre data. We trained two state-of-the-art fully convolutional CNN architectures on the 2016 MSSEG training dataset, which was annotated by seven independent human raters: a reference implementation of a 3D Unet, and a more recently proposed 3D-to-2D architecture (DeepSCAN). We then retrained those methods on a larger dataset from a single centre, with and without labels for other brain structures. We quantified changes in performance owing to dataset shift, and changes in performance by adding the additional brain-structure labels. We also compared performance with freely available reference methods. Both fully-convolutional CNN methods substantially outperform other approaches in the literature when trained and evaluated in cross-validation on the MSSEG dataset, showing agreement with human raters in the range of human inter-rater variability. Both architectures showed drops in performance when trained on single-centre data and tested on the MSSEG dataset. When trained with the addition of weak anatomical labels derived from Freesurfer, the performance of the 3D Unet degraded, while the performance of the DeepSCAN net improved. Overall, the DeepSCAN network predicting both lesion and anatomical labels was the best-performing network examined.

cs.CV↗

Automatic detection of lesion load change in Multiple Sclerosis using convolutional neural networks with segmentation confidence

The detection of new or enlarged white-matter lesions in multiple sclerosis is a vital task in the monitoring of patients undergoing disease-modifying treatment for multiple sclerosis. However, the definition of 'new or enlarged' is not fixed, and it is known that lesion-counting is highly subjective, with high degree of inter- and intra-rater variability. Automated methods for lesion quantification hold the potential to make the detection of new and enlarged lesions consistent and repeatable. However, the majority of lesion segmentation algorithms are not evaluated for their ability to separate progressive from stable patients, despite this being a pressing clinical use-case. In this paper we show that change in volumetric measurements of lesion load alone is not a good method for performing this separation, even for highly performing segmentation methods. Instead, we propose a method for identifying lesion changes of high certainty, and establish on a dataset of longitudinal multiple sclerosis cases that this method is able to separate progressive from stable timepoints with a very high level of discrimination (AUC = 0.99), while changes in lesion volume are much less able to perform this separation (AUC = 0.71). Validation of the method on a second external dataset confirms that the method is able to generalize beyond the setting in which it was trained, achieving an accuracy of 83% in separating stable and progressive timepoints. Both lesion volume and count have previously been shown to be strong predictors of disease course across a population. However, we demonstrate that for individual patients, changes in these measures are not an adequate means of establishing no evidence of disease activity. Meanwhile, directly detecting tissue which changes, with high confidence, from non-lesion to lesion is a feasible methodology for identifying radiologically active patients.

cs.CV↗